Abstract
Transmissible spongiform encephalopathies such as scrapie are caused by a protein-only infectious agent, known as a prion. It is not clear how a protein can be capable of replicating itself, and the mechanism remains controversial. One influential model hypothesizes that prions are nucleated, macroscopically linear polymers. We investigated the theoretical kinetics of this model and derived predictions which could be used to test the model. In the model, the polymerization and depolymerization rates are independent polymer size. This leads to an exponential size distribution at equilibrium. In agreement with a prediction stemming from this size distribution, the average size of PrP-res polymers was proportional to the square root of the concentration of PrP-res in a published study of in vitro conversion. Prion digestion by proteinase K (PK) is predicted to be biphasic. The second phase of digestion should be virtually independent of the PK concentration and should depend on the initial size distribution of prion polymers. For initially equilibrated polymers with an exponential size distribution, phase two digestion is exponential at a predicted rate. This rate varies in a defined way with the concentration used for equilibration and with other parameters which affect the average polymer size.
Full Text
The Full Text of this article is available as a PDF (119.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aguzzi A., Weissmann C. Prion research: the next frontiers. Nature. 1997 Oct 23;389(6653):795–798. doi: 10.1038/39758. [DOI] [PubMed] [Google Scholar]
- Buschmann A., Kuczius T., Bodemer W., Groschup M. H. Cellular prion proteins of mammalian species display an intrinsic partial proteinase K resistance. Biochem Biophys Res Commun. 1998 Dec 30;253(3):693–702. doi: 10.1006/bbrc.1998.9838. [DOI] [PubMed] [Google Scholar]
- Caughey B., Chesebro B. Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol. 1997 Feb;7(2):56–62. doi: 10.1016/S0962-8924(96)10054-4. [DOI] [PubMed] [Google Scholar]
- Caughey B., Kocisko D. A., Raymond G. J., Lansbury P. T., Jr Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol. 1995 Dec;2(12):807–817. doi: 10.1016/1074-5521(95)90087-x. [DOI] [PubMed] [Google Scholar]
- Chesebro B. BSE and prions: uncertainties about the agent. Science. 1998 Jan 2;279(5347):42–43. doi: 10.1126/science.279.5347.42. [DOI] [PubMed] [Google Scholar]
- Cohen F. E., Pan K. M., Huang Z., Baldwin M., Fletterick R. J., Prusiner S. B. Structural clues to prion replication. Science. 1994 Apr 22;264(5158):530–531. doi: 10.1126/science.7909169. [DOI] [PubMed] [Google Scholar]
- Eigen M. Prionics or the kinetic basis of prion diseases. Biophys Chem. 1996 Dec 10;63(1):A1–18. doi: 10.1016/s0301-4622(96)02250-8. [DOI] [PubMed] [Google Scholar]
- Griffith J. S. Self-replication and scrapie. Nature. 1967 Sep 2;215(5105):1043–1044. doi: 10.1038/2151043a0. [DOI] [PubMed] [Google Scholar]
- Harper J. D., Lansbury P. T., Jr Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem. 1997;66:385–407. doi: 10.1146/annurev.biochem.66.1.385. [DOI] [PubMed] [Google Scholar]
- Jackson G. S., Hosszu L. L., Power A., Hill A. F., Kenney J., Saibil H., Craven C. J., Waltho J. P., Clarke A. R., Collinge J. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science. 1999 Mar 19;283(5409):1935–1937. doi: 10.1126/science.283.5409.1935. [DOI] [PubMed] [Google Scholar]
- Jarrett J. T., Lansbury P. T., Jr Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 1993 Jun 18;73(6):1055–1058. doi: 10.1016/0092-8674(93)90635-4. [DOI] [PubMed] [Google Scholar]
- Jeffrey M., Goodbrand I. A., Goodsir C. M. Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructure. Micron. 1995;26(3):277–298. doi: 10.1016/0968-4328(95)00004-n. [DOI] [PubMed] [Google Scholar]
- Kawamura M., Maruyama K. Particle length of actomyosin measured by electron microscopy. J Biochem. 1969 Nov;66(5):619–626. [PubMed] [Google Scholar]
- Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T., Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 1994 Aug 11;370(6489):471–474. doi: 10.1038/370471a0. [DOI] [PubMed] [Google Scholar]
- Laurent M. Autocatalytic processes in cooperative mechanisms of prion diseases. FEBS Lett. 1997 Apr 21;407(1):1–6. doi: 10.1016/s0014-5793(97)00310-4. [DOI] [PubMed] [Google Scholar]
- Masel J., Jansen V. A., Nowak M. A. Quantifying the kinetic parameters of prion replication. Biophys Chem. 1999 Mar 29;77(2-3):139–152. doi: 10.1016/s0301-4622(99)00016-2. [DOI] [PubMed] [Google Scholar]
- McKinley M. P., Bolton D. C., Prusiner S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell. 1983 Nov;35(1):57–62. doi: 10.1016/0092-8674(83)90207-6. [DOI] [PubMed] [Google Scholar]
- Meyer R. K., McKinley M. P., Bowman K. A., Braunfeld M. B., Barry R. A., Prusiner S. B. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2310–2314. doi: 10.1073/pnas.83.8.2310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oosawa F. Size distribution of protein polymers. J Theor Biol. 1970 Apr;27(1):69–86. doi: 10.1016/0022-5193(70)90129-3. [DOI] [PubMed] [Google Scholar]
- Prusiner S. B. Molecular biology of prion diseases. Science. 1991 Jun 14;252(5012):1515–1522. doi: 10.1126/science.1675487. [DOI] [PubMed] [Google Scholar]
- Prusiner S. B. Prion diseases and the BSE crisis. Science. 1997 Oct 10;278(5336):245–251. doi: 10.1126/science.278.5336.245. [DOI] [PubMed] [Google Scholar]